Active Pharmaceutical Ingredient (API)

Depemokimab

Long-acting Anti-IL-5

A high-affinity, long-acting monoclonal antibody targeting IL-5. Designed for 6-monthly dosing in eosinophilic asthma.
Technical Profile
Reference Code
RES1036
CAS Number
2148332-15-4
Molecular Weight
144,000.00 g/mol
Chemical Class
N/A
Molecular Formula
Variable
Therapeutic Class
N/A

Verified Brands

Medicines containing Depemokimab as an active ingredient.

Brand Name Manufacturer Formulation MRP
No verified brands found for this salt.